Vaccine|HS Code

Vaccine harmonized system code

Product Overview A Vaccine, classified under HS Code 3002, is a biological product that stimulates the body's immune system to produce immunity to a specific disease, protecting the person from that disease. These vaccines are typically created from small amounts of weak or dead germs that can cause diseases such as viruses, bacteria, or toxins. Under HS Code 3002, vaccines are subcategorized based on their application, including human vaccines (300210) and veterinary vaccines (300230). Commercial applications of vaccines are vast, extending from health service providers and clinics to veterinary practices and livestock industries. The value proposition of vaccines under HS Code 3002 lies in their ability to prevent diseases, thereby reducing healthcare costs and improving overall community health. The competitive advantage of these vaccines is their rigorous testing and stringent regulatory approval process, which ensures safety and efficacy. HS Code Classification & Trade Specifications HS Code 3002 breaks down hierarchically into Chapter 30 (Pharmaceutical products), Heading 02 (Human and Animal Blood; Vaccines, toxins, cultures of micro-organisms), and Subheading 3002 (Vaccines for human medicine). The classification of vaccines under this specific code is based on their biological nature and critical role in preventing diseases in humans and animals. Trade considerations for vaccines include special packaging to maintain the cold chain, preservation methods to ensure product integrity, and shipping requirements that comply with international health and safety regulations. Vaccines under HS Code 3002 are held to high-quality standards dictated by international health organizations like the World Health Organization (WHO) and the Food and Drug Administration (FDA). These standards include specific measurable attributes such as purity, potency, sterility, and safety. As the vaccine trade is subject to strict regulation and compliance, it aligns with WTO and customs documentation standards, maintaining consistency with international trade classification systems.

Vaccine Chapter Note

1.- This Chapter does not cover : (a) Foods or beverages (such as dietetic, diabetic or fortified foods, food supplements, tonic beverages and mineral waters), other than nutritional preparations for intravenous administration (Section IV); (b) Products, such as tablets, chewing gum or patches (transdermal systems), containing nicotine and intended to assist tobacco use cessation (heading 24.04); (c) Plasters specially calcined or finely ground for use in dentistry (heading 25.20); (d) Aqueous distillates or aqueous solutions of essential oils, suitable for medicinal uses (heading 33.01); (e) Preparations of headings 33.03 to 33.07, even if they have therapeutic or prophylactic properties; (f) Soap or other products of heading 34.01 containing added medicaments; (g) Preparations with a basis of plaster for use in dentistry (heading 34.07); (h) Blood albumin not prepared for therapeutic or prophylactic uses (heading 35.02); or (ij) Diagnostic reagents of heading 38.22. 2.- For the purposes of heading 30.02, the expression “immunological products” applies to peptides and proteins (other than goods of heading 29.37) which are directly involved in the regulation of immunological processes, such as monoclonal antibodies (MAB), antibody fragments, antibody conjugates and antibody fragment conjugates, interleukins, interferons (IFN), chemokines and certain tumor necrosis factors (TNF), growth factors (GF), hematopoietins and colony stimulating factors (CSF). 3.- For the purposes of headings 30.03 and 30.04 and of Note 4 (d) to this Chapter, the following are to be treated : (a) As unmixed products : (1) Unmixed products dissolved in water; (2) All goods of Chapter 28 or 29; and (3) Simple vegetable extracts of heading 13.02, merely standardised or dissolved in any solvent; (b) As products which have been mixed : (1) Colloidal solutions and suspensions (other than colloidal sulphur); (2) Vegetable extracts obtained by the treatment of mixtures of vegetable materials; and (3) Salts and concentrates obtained by evaporating natural mineral waters. 4.- Heading 30.06 applies only to the following, which are to be classified in that heading and in no other heading of the Nomenclature : (a) Sterile surgical catgut, similar sterile suture materials (including sterile absorbable surgical or dental yarns) and sterile tissue adhesives for surgical wound closure; (b) Sterile laminaria and sterile laminaria tents; (c) Sterile absorbable surgical or dental haemostatics; sterile surgical or dental adhesion barriers, whether or not absorbable; (d) Opacifying preparations for X-ray examinations and diagnostic reagents designed to be administered to the patient, being unmixed products put up in measured doses or products consisting of two or more ingredients which have been mixed together for such uses; (e) Placebos and blinded (or double-blinded) clinical trial kits for use in recognised clinical trials, put up in measured doses, even if they might contain active medicaments; (f) Dental cements and other dental fillings; bone reconstruction cements; (g) First-aid boxes and kits;(h) Chemical contraceptive preparations based on hormones, on other products of heading 29.37 or on spermicides; (ij) Gel preparations designed to be used in human or veterinary medicine as a lubricant for parts of the body for surgical operations or physical examinations or as a coupling agent between the body and medical instruments; (k) Waste pharmaceuticals, that is, pharmaceutical products which are unfit for their original intended purpose due to, for example, expiry of shelf life; and (l) Appliances identifiable for ostomy use, that is, colostomy, ileostomy and urostomy pouches cut to shape and their adhesive wafers or faceplates.